Catalyst

Slingshot members are tracking this event:

Phase 3 Data from Second Epidiolex Lennox-Gastaut Syndrome Study due H2 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GWPH

100%
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3 Data, Dravet Syndrome, Epilepsy, Epidiolex